Proliferative T Cell Responses to Four Human Cytomegalovirus-Specific Proteins in Healthy Subjects and Solid Organ Transplant Recipients

1995 ◽  
Vol 172 (3) ◽  
pp. 879-882 ◽  
Author(s):  
J. van Zanten ◽  
M. C. Harmsen ◽  
P. van der Meer ◽  
W. van der Bij ◽  
W. J. van Son ◽  
...  
2001 ◽  
Vol 41 (12) ◽  
pp. 1271-1279 ◽  
Author(s):  
Ms. Vera S. Donnenberg ◽  
Gilbert J. Burckart ◽  
Bartley P. Griffith ◽  
Ashok B. Jain ◽  
Adriana Zeevi ◽  
...  

1999 ◽  
Vol 6 (4) ◽  
pp. 621-623 ◽  
Author(s):  
Bodo R. Eing ◽  
Horst G. Baumeister ◽  
Joachim E. Kuehn ◽  
Guenter May

ABSTRACT The retrospective analysis of 494 solid-organ transplant recipients revealed that during the follow-up period (mean duration, 3.2 years) 184 (88%) of 209 anti-human cytomegalovirus (HCMV) immunoglobulin A (IgA)-positive patients remained IgA positive, as did 128 (74.85%) of 171 anti-HCMV IgM-positive patients. We conclude that anti-HCMV IgA and IgM testing for management of clinically relevant HCMV infections in solid-organ transplant recipients is dispensable.


Sign in / Sign up

Export Citation Format

Share Document